Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 25/11/21

Trade details

Type
Insider sale
Amount
$1,164,779
Shares · price
2,450 sh · $475.42 a share
Held after
180 sh
Trade date
25/11/21
Filed
25/11/21
Days to filing
0 days

Sold 93.2% of holdings

Share of holding sold
93.2%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/22~25/12/21

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $1.2M of United Therapeutics UTHR · 93.2% of holdings · 10b5-1 plan | Whalegun